CXCL8 and acute respiratory distress syndrome: Furthermore, they may increase levels of vascular endothelial growth factor (VEGF), monocyte chemotactic protein-1 (MCP-1), and interleukin-8 (IL-8) levels, as well as release of IL-6 and reduction of E-cadherin, eventually leading to acute respiratory distress syndrome (ARDS).